ABSTRACT
Specific allergen immunotherapy is the accepted practice among allergy specialists throughout the world for the treatment of selected patients with respiratory atopic allergy or Hymenoptera venom anaphylaxis. The majority of placebo-controlled clinical trials document its efficacy and, therefore, support its use.
